Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pow-Sang

Showing results (151-160 of 264) with videos related to

Pageof 27
Sort By:
Psycho-Oncology|February 27, 2010
Psychosocial issues related to sexual functioning among African-American prostate cancer survivors and their spousesBrian M Rivers, Euna M August, Clement K Gwede, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Chemoprevention in African American Men With Prostate CancerNagi B Kumar, Julio M Pow-Sang, Philippe E Spiess, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Extracellular microvesicle microRNAs, along with imaging metrics, improve detection of aggressive prostate cancerKapil K Avasthi, Jung Choi, Tetiana Glushko, et al.
BJU International|May 9, 2012
Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinomaSandhya R Rao, Jose J Correa, Wade J Sexton, et al.
Urologic Oncology|June 22, 2015
Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinomaPranav Sharma, Kamran Zargar-Shoshtari, Jamie T Caracciolo, et al.
Urologic Oncology|September 12, 2006
Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experienceJavier F Torres-Roca, Alan B Cantor, Sonia Shukla, et al.
Archivos Espanoles De Urologia|September 24, 2004
[Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics]Sharon Saavedra Jo, Mariela Pow-Sang Godoy, Víctor Benavente Corrales, et al.
Journal of the American College of Surgeons|February 15, 2016
Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic LymphadenectomyLesly A Dossett, Nicholas B Castner, Julio M Pow-Sang, et al.
Nutrition and Cancer|November 16, 2007
A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancerNagi B Kumar, Jeffrey P Krischer, Kathy Allen, et al.
Nutrition and Cancer|November 16, 2007
Safety of purified isoflavones in men with clinically localized prostate cancerNagi B Kumar, Jeffrey P Krischer, Kathy Allen, et al.
Pageof 27

Showing results (151-160 of 264) with videos related to

Sort By:
Pageof 27
Psycho-Oncology|February 27, 2010
Psychosocial issues related to sexual functioning among African-American prostate cancer survivors and their spousesBrian M Rivers, Euna M August, Clement K Gwede, et al.
Cancer Control : Journal of the Moffitt Cancer Center|November 15, 2016
Chemoprevention in African American Men With Prostate CancerNagi B Kumar, Julio M Pow-Sang, Philippe E Spiess, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Extracellular microvesicle microRNAs, along with imaging metrics, improve detection of aggressive prostate cancerKapil K Avasthi, Jung Choi, Tetiana Glushko, et al.
BJU International|May 9, 2012
Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinomaSandhya R Rao, Jose J Correa, Wade J Sexton, et al.
Urologic Oncology|June 22, 2015
Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinomaPranav Sharma, Kamran Zargar-Shoshtari, Jamie T Caracciolo, et al.
Urologic Oncology|September 12, 2006
Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: a review of the H. Lee Moffitt Cancer Center experienceJavier F Torres-Roca, Alan B Cantor, Sonia Shukla, et al.
Archivos Espanoles De Urologia|September 24, 2004
[Xanthogranulomatous pyelonephritis: clinical, radiological and pathologic characteristics]Sharon Saavedra Jo, Mariela Pow-Sang Godoy, Víctor Benavente Corrales, et al.
Journal of the American College of Surgeons|February 15, 2016
Robotic-Assisted Transperitoneal Pelvic Lymphadenectomy for Metastatic Melanoma: Early Outcomes Compared with Open Pelvic LymphadenectomyLesly A Dossett, Nicholas B Castner, Julio M Pow-Sang, et al.
Nutrition and Cancer|November 16, 2007
A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancerNagi B Kumar, Jeffrey P Krischer, Kathy Allen, et al.
Nutrition and Cancer|November 16, 2007
Safety of purified isoflavones in men with clinically localized prostate cancerNagi B Kumar, Jeffrey P Krischer, Kathy Allen, et al.
Pageof 27